Beacon Financial Group Novartis Ag Transaction History

Beacon Financial Group

$913 Million
Q3 2024

A detailed history of Beacon Financial Group transactions in Novartis Ag stock. As of the latest transaction made, Beacon Financial Group holds 21,849 shares of NVS stock, worth $2.16 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

21,849

Previous 22,620 3.41%

Holding current value

$2.16 Million

Previous $2.41 Million 4.36%

% of portfolio

0.28%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $81,826 - $93,206	-771 Reduced 3.41%	21,849 $2.51 Million
Q2 2024 Aug 06, 2024	SELL	$92.57 - $107.37 $15,459 - $17,930	-167 Reduced 0.73%	22,620 $2.41 Million
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $114,705 - $130,597	-1,204 Reduced 5.02%	22,787 $2.2 Million
Q4 2023 Feb 23, 2024	BUY	$92.27 - $101.54 $70,402 - $77,475	763 Added 3.28%	23,991 $2.42 Million
Q3 2023 Oct 16, 2023	SELL	$94.73 - $105.13 $460,861 - $511,457	-4,865 Reduced 17.32%	23,228 $2.33 Million
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $114,817 - $130,193	-1,241 Reduced 4.23%	28,093 $2.79 Million
Q1 2023 Apr 14, 2023	SELL	$80.03 - $92.81 $315,478 - $365,857	-3,942 Reduced 11.85%	29,334 $2.81 Million
Q4 2022 Jan 19, 2023	BUY	$75.55 - $92.52 $26,820 - $32,844	355 Added 1.08%	33,276 $3.03 Million
Q3 2022 Oct 13, 2022	BUY	$74.61 - $87.26 $103,782 - $121,378	1,391 Added 4.41%	32,921 $2.53 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $20,049 - $23,343	-249 Reduced 0.78%	31,530 $2.65 Million
Q1 2022 Apr 08, 2022	BUY	$80.11 - $90.62 $117,441 - $132,848	1,466 Added 4.84%	31,779 $2.81 Million
Q4 2021 Jan 07, 2022	BUY	$79.7 - $88.13 $20,881 - $23,090	262 Added 0.87%	30,313 $2.66 Million
Q3 2021 Oct 13, 2021	BUY	$81.78 - $95.14 $63,870 - $74,304	781 Added 2.67%	30,051 $2.49 Million
Q2 2021 Jul 26, 2021	BUY	$85.24 - $94.15 $189,914 - $209,766	2,228 Added 8.24%	29,270 $2.64 Million
Q4 2020 Jan 15, 2021	SELL	$78.07 - $94.43 $23,030 - $27,856	-295 Reduced 1.08%	27,042 $2.56 Million
Q3 2020 Oct 13, 2020	SELL	$82.14 - $91.0 $125,345 - $138,866	-1,526 Reduced 5.29%	27,337 $2.38 Million
Q2 2020 Aug 05, 2020	SELL	$80.93 - $91.1 $3,479 - $3,917	-43 Reduced 0.15%	28,863 $2.52 Million
Q1 2020 Jun 29, 2020	BUY	$70.67 - $99.01 $19,858 - $27,821	281 Added 0.98%	28,906 $2.37 Million
Q4 2019 Jan 17, 2020	BUY	$84.35 - $95.37 $191,390 - $216,394	2,269 Added 8.61%	28,625 $2.71 Million
Q3 2019 Oct 15, 2019	SELL	$85.54 - $94.26 $57,397 - $63,248	-671 Reduced 2.48%	26,356 $2.3 Million
Q2 2019 Jul 15, 2019	SELL	$75.4 - $92.8 $904 - $1,113	-12 Reduced 0.04%	27,027 $2.47 Million
Q1 2019 Apr 18, 2019	SELL	$75.32 - $86.15 $7,682 - $8,787	-102 Reduced 0.38%	27,039 $2.6 Million
Q4 2018 Jan 16, 2019	SELL	$73.66 - $82.02 $113,583 - $126,474	-1,542 Reduced 5.38%	27,141 $2.31 Million
Q3 2018 Oct 10, 2018	SELL	$66.94 - $77.43 $66,069 - $76,423	-987 Reduced 3.33%	28,683 $2.47 Million
Q2 2018 Jul 11, 2018	SELL	$64.91 - $73.36 $83,279 - $94,120	-1,283 Reduced 4.14%	29,670 $2.24 Million
Q1 2018 Apr 06, 2018	SELL	$70.39 - $84.15 $10,910 - $13,043	-155 Reduced 0.5%	30,953 $2.5 Million
Q4 2017 Jan 03, 2018	BUY	$72.33 - $77.64 $16,563 - $17,779	229 Added 0.74%	31,108 $2.61 Million
Q3 2017 Oct 03, 2017	BUY	$74.14 - $77.27 $2.29 Million - $2.39 Million	30,879	30,879 $2.65 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Group with notifications on news.

Account

Beacon Financial Group Novartis Ag Transaction History